ADVANCED SYSTEMIC MASTOCYTOSIS

This adverse event was reported 18 times

These drugs are most commonly taken by patients reporting ADVANCED SYSTEMIC MASTOCYTOSIS:

# Drug Count
0 RITUXIMAB 5
1 CYCLOPHOSPHAMIDE 4
2 CYCLOPHOSPHAMIDE FOR INJECTION 4
3 CYCLOPHOSPHAMIDE INJECTION, SOLUTION 4
4 PREDNISONE 4
5 AVAPRITINIB 3
6 DOXORUBICIN 2
7 RYDAPT 2
8 DOXORUBICIN HYDROCHLORIDE 1
9 FAMOTIDINE 1
See all common drugs associated with ADVANCED SYSTEMIC MASTOCYTOSIS

ADVANCED SYSTEMIC MASTOCYTOSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 RYDAPT 2 0.0010
1 NILOTINIB 1 0.0000
2 DOXORUBICIN HYDROCHLORIDE 1 0.0000
3 RITUXIMAB 5 0.0000
4 CYCLOPHOSPHAMIDE FOR INJECTION 4 0.0000
5 CYCLOPHOSPHAMIDE 4 0.0000
6 DOXORUBICIN 2 0.0000
7 OMALIZUMAB 1 0.0000
8 FAMOTIDINE 1 0.0000
9 PREDNISONE 4 0.0000
See all drugs enriched for association with ADVANCED SYSTEMIC MASTOCYTOSIS

ADVANCED SYSTEMIC MASTOCYTOSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Alkylating Drug [EPC] 4 0.0000
1 CD20-directed Cytolytic Antibody [EPC] 5 0.0000
2 Anti-IgE [EPC] 1 0.0000
3 Histamine-2 Receptor Antagonist [EPC] 1 0.0000
4 Kinase Inhibitor [EPC] 2 0.0000
5 Corticosteroid [EPC] 4 0.0000
See all drug classes enriched for association with ADVANCED SYSTEMIC MASTOCYTOSIS